Advanced delivery systems, including encapsulation in liposomes or conjugation with lipid-based carriers, are often employed to enhance penetration and protect peptides from enzymatic degradation, thereby amplifying their therapeutic efficacy
While those can be effective, they often come with a longer list of potential side effects and can feel more like a medical intervention
While it ensures direct systemic absorption, it is less patient-friendly and may result in reduced treatment adherence
In Summary, while early research in animal models points toward potential healing and regenerative properties for BPC-157, the complete lack of well-designed human clinical trials makes it a gamble
We treat patients of all ages, from pediatric to adult care, under one roof
Here, well break down how the different delivery methods change things